EmpaMet 5 mg+850 mg (Tablet)
Unit Price: ৳ 22.00 (4 x 8: ৳ 704.00)
Strip Price: ৳ 176.00
Medicine Details
Category | Details |
---|---|
Generic | Empagliflozin metformin hydrochloride |
Company | Nipro jmi pharma ltd |
Also available as |
Indications
- Treatment of adults with type 2 diabetes mellitus
- Adjunct to diet and exercise
- Insufficiently controlled on Metformin alone
- Combination with other medicinal products for diabetes
- Usable for patients on Empagliflozin and Metformin separately
Pharmacology
- Inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2)
- Reduces renal reabsorption of filtered glucose
- Lowers renal threshold for glucose
- Increases urinary glucose excretion
- Biguanide type oral antihyperglycemic drug
- Lowers basal and postprandial plasma glucose
- Increases peripheral glucose uptake and utilization
Dosage & Administration
- Individualized dosage based on effectiveness and tolerability
- Take twice daily with meals
- Maximum recommended daily doses: 2000 mg Metformin, 25 mg Empagliflozin
- Extended-release formulations available
- Dosing adjustment for renal impaired patients
- Not recommended for pediatric patients under 18 years of age
Interaction
- Increased urine volume and frequency with diuretics
- Increased risk of hypoglycemia with insulin or insulin secretagogues
- Monitoring glycemic control with urine glucose test not recommended
- Drugs that reduce Metformin clearance may increase accumulation
- Carbonic Anhydrase Inhibitors may increase risk of lactic acidosis
- Other drugs affecting glycemic control
Contraindications
- Hypersensitivity to Empagliflozin and Metformin
- Acute metabolic acidosis
- Severe renal failure (GFR < 30 ml/min)
- Acute conditions altering renal function
- Diseases causing tissue hypoxia
- Hepatic impairment, acute alcohol intoxication, alcoholism
Side Effects
- Urinary tract infection
- Female genital mycotic infections
- Diarrhea
- Nausea/vomiting
- Flatulence
- Abdominal discomfort
- Indigestion
- Asthenia
- Headache
- Hypoglycemia
- Vaginal moniliasis
- Thirst
- Taste disturbance
- Pruritus (generalised)
- Rash
- Increased urination
- Increased serum lipids
- Volume depletion
- Urticaria
- Dysuria
- Increased blood creatinine/Glomerular filtration rate
- Rare: Diabetic ketoacidosis
Pregnancy & Lactation
- Potential risk to fetus during second and third trimesters
- Not recommended during breastfeeding
Precautions & Warnings
- Lactic Acidosis
- Hypotension
- Ketoacidosis
- Acute kidney injury & impairment
- Urosepsis, Pyelonephritis, Fournier’s gangrene & Genital mycotic infections
- Hypoglycemia risk
- Vitamin B12 Deficiency
- Increased LDL-C
- Lack of evidence for macrovascular risk reduction
Overdose Effects
- No toxicity observed at high single or multiple doses
- Lactic acidosis risk with high Metformin doses
- Hypoglycemia not seen with Metformin overdoses
- Medical emergency requiring hospital treatment
- Haemodialysis for lactate and Metformin removal
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Keep below 30°C temperature
- Protected from light & moisture
- Keep out of the reach of children
Related Brands
- EmpaMet XR 5 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd
- EmpaMet XR 10 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd
- EmpaMet XR 25 mg+1000 mg (Tablet (Extended Release)) - nipro-jmi-pharma-ltd
- EmpaMet 5 mg+1000 mg (Tablet) - nipro-jmi-pharma-ltd
- EmpaMet 12.5 mg+850 mg (Tablet) - nipro-jmi-pharma-ltd